A Flow-Cytometry-Based Approach to Facilitate Quantification, Size Estimation and Characterization of Sub-visible Particles in Protein Solutions

Pharmaceutical Research
Christian LubichBirgit M Reipert

Abstract

Sub-visible particles were shown to facilitate unwanted immunogenicity of protein therapeutics. To understand the root cause of this phenomenon, a comprehensive analysis of these particles is required. We aimed at establishing a flow-cytometry-based technology to analyze the amount, size distribution and nature of sub-visible particles in protein solutions. We adjusted the settings of a BD FACS Canto II by tuning the forward scatter and the side scatter detectors and by using size calibration beads to facilitate the analysis of particles with sizes below 1 μM. We applied a combination of Bis-ANS (4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid dipotassium salt) and DCVJ (9-(2,2-dicyanovinyl)julolidine) to identify specific characteristics of sub-visible particles. The FACS technology allows the analysis of particles between 0.75 and 10 μm in size, requiring relatively small sample volumes. Protein containing particles can be distinguished from non-protein particles and cross-β-sheet structures contained in protein particles can be identified. The FACS technology provides robust and reproducible results with respect to number, size distribution and specific characteristics of sub-visible particles between 0.75 and 10 μm in s...Continue Reading

References

Sep 1, 2000·International Journal of Pharmaceutics·W Wang
Feb 15, 2002·The New England Journal of Medicine·Nicole CasadevallPatrick Mayeux
Aug 23, 2002·Pharmaceutical Biotechnology·Michael J AkersMary Stickelmeyer
Oct 2, 2004·Protein Science : a Publication of the Protein Society·Peter B StathopulosElizabeth M Meiering
Dec 4, 2004·The Journal of Biological Chemistry·Mantas MalisauskasLudmilla A Morozova-Roche
Mar 1, 2005·Journal of Pharmaceutical Sciences·Latoya S JonesC Russell Middaugh
Nov 24, 2005·The FEBS Journal·Thomas R Jahn, Sheena E Radford
Apr 28, 2006·Statistics in Medicine·UNKNOWN Committee for Medicinal Products for Human UseUNKNOWN Committee for Release for Consultation
Oct 10, 2006·The AAPS Journal·Amy S Rosenberg
Dec 1, 2006·The Journal of Biological Chemistry·Coen MaasMartijn F B G Gebbink
May 1, 2007·Nature·Michael R SawayaDavid Eisenberg
Sep 6, 2007·Journal of Pharmaceutical Sciences·Andrea Hawe, Wolfgang Friess
Dec 22, 2007·Nature Reviews. Drug Discovery·Benjamin LeaderDavid E Golan
Aug 16, 2008·Journal of Pharmaceutical Sciences·John F CarpenterBarry Cherney
Apr 11, 2009·Journal of Pharmaceutical Sciences·Renuka ThirumangalathuJohn F Carpenter
Dec 8, 2009·Trends in Pharmacological Sciences·Melody SauerbornHuub Schellekens
Mar 2, 2010·Nature Reviews. Drug Discovery·Adriano Aguzzi, Tracy O'Connor
Oct 26, 2010·Pharmaceutical Research·John den EngelsmanWim Jiskoot
Feb 26, 2011·Current Protein & Peptide Science·Carlos W Bertoncini, M Soledad Celej
Mar 1, 2011·Biologicals : Journal of the International Association of Biological Standardization·I C BüttelC K Schneider
Mar 5, 2011·Journal of Pharmaceutical Sciences·Henryk MachRobert K Evans
Apr 14, 2011·Self/nonself·Matthew P BakerChristine J Bryson
Jan 20, 2012·Rheumatology·Rachel A FarrellPaul I Creeke
Jan 22, 2013·Cellular and Molecular Life Sciences : CMLS·Adelin GustotCaroline Lonez
Jan 22, 2013·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·John P Nolan, Samuel A Stoner
Mar 7, 2013·Journal of Pharmaceutical Sciences·Sarah ZöllsAndrea Hawe
Mar 9, 2013·Toxicologic Pathology·Nancy E Everds, Jacqueline M Tarrant
Aug 8, 2013·Journal of Immunotoxicology·Kirsty D RatanjiIan Kimber
Nov 13, 2013·Journal of Pharmaceutical Sciences·Hirotaka NishiGerhard Winter
Apr 15, 2014·Journal of Pharmaceutical Sciences·Alana GerhardtTheodore W Randolph
Sep 14, 2014·Biochemistry·Wojciech PaslawskiDaniel E Otzen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.